Archive | November, 2009
Silenor Approaching FDA Decision Date (SOMX)
Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical company that focuses on in-licensing, developing and bringing to market treatments for psychological and neurological disorders, has announced that the US Food and Drug Administration (FDA) had given it a new Prescription Drug User Fee Act (PDUFA) target action date of December 4, 2009 after accepting its [...]
Continue reading...Simulations Plus’ New Software Version (NASDAQ:SLP)
30 November 2009 – 7:15 am PST
Comments Off
Simulations Plus, Inc (NASDAQ:SLP) has announced that they have released the new version of GastroPlus state of the art software which is being used by many pharmaceutical research scientists for simulation of oral absorption, intravenous dosing, pharmacokinetics, and pharmacodynamics.
Continue reading...Healthways’ Fitness Program (NASDAQ:HWAY)
30 November 2009 – 7:05 am PST
Comments Off
Healthways, Inc. (NASDAQ:HWAY) and Physicians Health Choice together have announced an agreement to provide the Healthways SilverSneakers Fitness Program to eligible Physicians Health Choice plan members in Texas, Florida, Arkansas and New Mexico that will begin from the very first month in 2010.
Continue reading...Cheerful Shoppers vs. Grumpy Accountants
30 November 2009 – 6:00 am PST
Comments Off
Whether you believe the economy is going to substantially improve over the next year, stay about the same, or get worse, you can find surveys that back up your point of view. Economic experts are always out there bothering people with survey questions, collating the data and reading the future from the results—almost like fortune [...]
Continue reading...Dyax approaching its PDUFA Date (DYAX)
24 November 2009 – 11:41 am PST
Comments Off
On 8 June 2009, Dyax Corp. (NASDAQ:DYAX), a clinical stage biopharmaceutical company that discovers, develops and commercializes biotherapeutics for inflammatory and oncology diseases, announced that it had obtained from the US Food and Drug Administration a new
Continue reading...FDA Decision scheduled for Santarus (SNTS)
23 November 2009 – 11:19 am PST
Comments Off
Santarus, Inc. (NASDAQ:SNTS)Â expects the FDA to decide by December 4, 2009 regarding its NDA for ZEGERID tablet product. A NDA (New Drug Application) for DM-1796 is also expected to be filed with the FDA the first quarter of 2010.
Continue reading...CytRx Technical Breakout on Pending News (NASDAQ:CYTR)
23 November 2009 – 10:58 am PST
Comments Off
Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/23/09 on CytRx Corporation (NASDAQ:CYTR). Shares of the company finished trading during 11/20/09 at $1.14Â per share.
Continue reading...Will the $20 million payment for VIBATIV pay off? (THRX, JNJ, ALPMF)
23 November 2009 – 7:10 am PST
Comments Off
The FDA is anticipated to decide on 11/26/09 for Vibativ (telavancin)Â as a once-daily injectable antibiotic for the treatment of hospital-acquired pneumonia (HAP). This triggers a milestone payment of $10M from THRX’s partner, Astellas Pharma (ALPMF.PK).
Continue reading...What You Need to Know about Home Equity Loans
23 November 2009 – 6:45 am PST
Comments Off
Many home owners want to pull some equity out of their home (if they were lucky enough to buy before the real estate boom then bust) and use the proceeds to pay off debt or use as a nest egg. Â
Continue reading...Echo Therapeutics Bullish on Recent News (OTC:ECTE)
20 November 2009 – 5:32 pm PST
Comments Off
MivInvestments Inc. has initiated an independent bullish technical trading alert for 11/20/09 on Echo Therapeutics, Inc. (OTC:ECTE.OB). Shares of the company finished the day at $1.35, up 8.15% from the opening bell on heavy buying pressure. The excitement was due to the announcement on positive results of a clinical study testing symphony(TM) tCGM System in [...]
Continue reading...
30 November 2009 – 7:30 am PST
Comments Off